Live News Categoriesequity

Carisma Therapeutics, Inc. (CARM) News

Follow Carisma Therapeutics, Inc. (CARM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol CARM Asset equity Sector Markets 90 days 2 Last 0.1514 Updated Oct 22, 2026, 03:42 PM UTC Open live news feed Open CARM chart & news

M Carmila Reports 9-Month Retailer Sales Up 3.2% Like-for-Like EQUITY | Oct 22, 2026, 03:42 PM UTC M Carmila Confirms FY Guidance at EUR1.87 Recurring EPS Carmila confirmed full-year guidance, citing recurring EPS of EUR1.87. EARNINGS | Oct 22, 2026, 03:42 PM UTC